BlackRock Group LTD - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Group LTD ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2016$5,887,000
+15.5%
55,913
+21.3%
0.00%0.0%
Q3 2016$5,095,000
-20.0%
46,099
+5.3%
0.00%0.0%
Q2 2016$6,372,000
+51.0%
43,766
+48.6%
0.00%
+50.0%
Q1 2016$4,219,000
+32.5%
29,450
+43.0%
0.00%0.0%
Q4 2015$3,183,00020,5960.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q4 2016
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders